ID   LaNCE hiPSC-16
SY   hiPSC-16; IPSC16; iPS-16; LANCEi020-A
DR   hPSCreg; LANCEi020-A
DR   Wikidata; Q95981220
RX   PubMed=29433076;
RX   PubMed=34174776;
CC   From: National Laboratory of Embryonic Stem Cell (LaNCE), University of Sao Paulo; Sao Paulo; Brazil.
CC   Derived from sampling site: Peripheral blood.
ST   Source(s): PubMed=29433076
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 11,16
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 23-09-21; Version: 5
RX   PubMed=29433076; DOI=10.1016/j.scr.2018.01.030;
RA   Sarafian R.D., Morato-Marques M., Borsoi J., Pereira L.V.;
RT   "Monitoring cell line identity in collections of human induced
RT   pluripotent stem cells.";
RL   Stem Cell Res. 28:66-70(2018).
RX   PubMed=34174776; DOI=10.1016/j.scr.2021.102434;
RA   Borsoi J., Farinha-Arcieri L.E., Morato-Marques M., Sarafian R.D.,
RA   Pinheiro M., Pereira L.V.;
RT   "Generation of genetically modified human induced pluripotent stem
RT   cell lines harboring haploin sufficient or dominant negative variants
RT   in the FBN1 gene.";
RL   Stem Cell Res. 54:102434-102434(2021).